300 related articles for article (PubMed ID: 4855167)
1. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
Thier SO; Wessler S; Avioli LV
Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
[No Abstract] [Full Text] [Related]
2. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
Blétry O; Cartier P; Hamet M; Clauvel JP
Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
[No Abstract] [Full Text] [Related]
3. The physiologic approach to hyperuricemia.
Rastegar A; Thier SO
N Engl J Med; 1972 Mar; 286(9):470-6. PubMed ID: 4550616
[No Abstract] [Full Text] [Related]
4. Gout and uric acid metabolism.
Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
[No Abstract] [Full Text] [Related]
5. [Uric acid and its metabolism].
Kissel P; Royer R
Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
[No Abstract] [Full Text] [Related]
6. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
[No Abstract] [Full Text] [Related]
7. [Observations on a random group of gout patients].
Einaudi G; Marrazzi G; Pecchiura G
Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
[No Abstract] [Full Text] [Related]
8. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
Emmerson BT
Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
[No Abstract] [Full Text] [Related]
9. [Current biochemical acquisitions on pathogenesis of gout].
Marcolongo R
Reumatismo; 1971; 23(3):109-25. PubMed ID: 5150688
[No Abstract] [Full Text] [Related]
10. Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
Boyle JA; Seegmiller JE
Mod Trends Rheumatol; 1971; 2():299-322. PubMed ID: 4949589
[No Abstract] [Full Text] [Related]
11. Management of gout and hyperuricemia.
Wisner DE; Simkin PA
Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
[TBL] [Abstract][Full Text] [Related]
12. [Gout].
Radi I
Schweiz Med Wochenschr; 1970 Feb; 100(8):383-6. PubMed ID: 4946973
[No Abstract] [Full Text] [Related]
13. Hyperuricemia and gout: an update.
Khachadurian AK
Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
[TBL] [Abstract][Full Text] [Related]
14. Gout.
JAMA; 1973 Apr; 224(5 Suppl):757-66. PubMed ID: 4349285
[No Abstract] [Full Text] [Related]
15. Editorial: Drugs used in hyperuricaemia.
S Afr Med J; 1974 Jun; 48(30):1278. PubMed ID: 4851506
[No Abstract] [Full Text] [Related]
16. [Therapeutic agents for gout effecting the kidney].
Ueda Y; Kono H; Kobayashi Y; Kagawa K; Yonezawa H
Geka Chiryo; 1970 Mar; 22(3):317-22. PubMed ID: 5467650
[No Abstract] [Full Text] [Related]
17. [Gout, archetype of diseases caused by deposits].
Delbarre F; de Gery A
Ann Biol Clin (Paris); 1972; 30(6):637-67. PubMed ID: 4567260
[No Abstract] [Full Text] [Related]
18. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
Watts RW; Snedden W; Parker RA
Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
[No Abstract] [Full Text] [Related]
19. Should asymptomatic hyperuricaemia be treated?
Jeremy R
Med J Aust; 1972 Aug; 2(9):505-6. PubMed ID: 5083604
[No Abstract] [Full Text] [Related]
20. Regulation of uric acid formation.
N Engl J Med; 1968 Feb; 278(6):331-2. PubMed ID: 5638350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
